查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829231

2025年全球介入性肿瘤设备市场报告

Interventional Oncology Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，介入性肿瘤器械市场规模稳定成长，从2024年的23.9亿美元扩张至2025年的25亿美元，复合年增长率为4.4%。这一增长归因于人口老化、癌症发生率上升、医药品研究开发费用增加、医疗保健支出增加以及医疗机构数量的增加。

预计未来几年介入肿瘤器械市场规模将强劲成长，2029年将达到32.8亿美元，年复合成长率（CAGR）为7.0%。预测期内的成长可归因于以下因素：老年人口的增加、对微创手术（MIS）的日益偏好、研发支出的增加、医疗保健支出的增加、新兴经济体的巨大潜力以及癌症和慢性病患病率的上升。预测期内的主要趋势包括：专注于开发先进的影像引导肿瘤治疗器械，利用人工智慧开发创新器械，开发能够改善肿瘤治疗的新型创新栓塞器械，并专注于利用机器人技术，以及与其他公司和研究机构合作加速产品开发和创新。

介入性肿瘤器材是专为癌症微创诊断和治疗而设计的专用医疗工具和技术。这些器械可以直接瞄准肿瘤，进行切除或栓塞等治疗，重点是摧毁癌细胞，同时保护附近的健康组织。

介入性肿瘤器械领域的关键产品包括栓塞器械、消融器械和支持器械。栓塞器械用于栓塞与各种肿瘤相关的血管。这些器械可用于热肿瘤消融、非热肿瘤消融、经导管动脉化疗栓塞术 (TACE)、经导管动脉放射栓塞术 (TARE)、选择性内放射线治疗(SIRT)、经导管动脉栓塞术 (TAE) 或缓释栓塞术等手术。这些治疗方法适用于治疗各种类型的癌症，包括肝癌、肾癌、肺癌和骨癌。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供介入肿瘤设备市场统计数据，例如全球市场规模、区域份额、介入性肿瘤设备市场份额竞争对手、详细的介入性肿瘤设备细分市场、市场趋势和商业机会，以及您在介入肿瘤设备行业取得成功所需的数据。本介入性肿瘤设备市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切资讯的完整观点。

未来五年7.0%的成长预测较我们先前对该市场的预测略有下降0.8%。下降的主要原因是美国与其他国家之间的关税影响，这可能会直接影响美国，导致放射栓塞微球和微波消融天线的供应链中断，而这些产品主要来自德国和以色列等主要产地。

介入肿瘤器械市场的主要企业正专注于组织产量等技术进步，以提高癌症治疗的诊断准确性和治疗效果。组织产量是切片检查中所获得的生物组织量。收集更多的组织样本可以进行更彻底的分析，提高诊断准确性并促进有效的治疗计划。例如，2023年6月，美国医疗设备製造商Argon Medical推出了半自动切片检查设备SuperCore Advantage。 SuperCore Advantage比竞争产品多收集高达35%的组织，减少了多次切片检查的需要，而多次活检对于获取足够的组织进行准确诊断至关重要。

癌症的高发生率预计将推动介入肿瘤器械市场的成长。癌症是一组以不受控制的细胞增殖为特征的疾病，会导致肿块或肿瘤的形成。癌症的高发生率催生了对介入性肿瘤器械的需求，这些器械对于癌症的诊断、治疗和管理至关重要，有助于早期发现、分期和监测。例如，2024年7月，澳洲健康与福利研究所报告称，澳洲确诊的癌症病例数将从2022年的160,570例增加到2023年的164,694例，较前一年大幅增加。这一趋势加剧了癌症发生率的上升，从而推动了市场对介入性肿瘤器械的需求。

介入肿瘤器材市场的公司越来越多地采用机器人技术来提高效率。机器人系统整合了基于影像的规划和导航功能，能够将器械精确且有效率地放置在特定的身体部位。 2022年3月，美国食品药物管理局核准了Quantum Surgical的Epione介入肿瘤机器人平台，彰显了该产业对技术进步的重视。

介入肿瘤设备市场的主要企业正专注于人工智慧数位病理解决方案等创新，以提高乳癌诊断的准确性。 2022年3月，美国生物技术公司Paige AI Inc.推出了「Paige乳腺淋巴结」解决方案，这是一款人工智慧数位病理解决方案，可提高乳癌淋巴结组织转移的检测率。该技术提供人工智慧检测功能、便捷的热图迭加、高灵敏度和特异性、与现有工作流程的无缝整合、易用性以及强大的安全措施。

2022年8月，波士顿科学公司（Boston Scientific Corporation）以未披露的金额收购了Obsidio Inc.，旨在扩大其介入肿瘤学产品组合，并巩固其在不断增长的市场中的地位。 Obsidio Inc.是一家美国医疗设备製造商，专门开髮用于治疗肝癌和其他固体癌的微创介入肿瘤学器材。

介入性肿瘤设备市场的主要参与者包括波士顿科学公司、泰尔茂公司、西门子医疗、Sirtex Medical Limited、Henlius、Viant Medical、AngioDynamics Inc、辉瑞公司、Steris Applied Sterilization Technologies、Dr. Reddys、CapeRay、信达生物製药、Medup、Consonance、ABLpbio、Adimmina、ABLna、Sirlee、ABLsbio、Saleeance、ABLsbio、Snalee、ABLa、Salee、ABLsone、Salee、ABLsone、Salee、ABLsone、Saconer​​l. biomedical、Olympus、科德宝医疗、海正药业、北京双鹭药业、Edwards LifeSciences Corp、Gulf Dent Trading、先健科技、Biomerics、美敦力公司、Dickinson & Company、3M Company、DISA Vascular、强生公司、Eurolab、荷兰皇家飞利浦公司、荷兰皇家飞利浦公司、Viak Ht. Medical、Gedeon Richter、百特公司Ti-TaMED、雅培实验室、库克医疗公司、Adavium Medical、Autocam Medical、Bio-Thera、史赛克、通用电气医疗集团、Sonic Healthcare、Medicem、HealthTronics、拜耳公司、Intuitive Surgical Inc、Aster Healthcare、丹纳赫、HealthTronics、拜耳公司、Intuitive Surgical Inc、Aster Healthcare、丹纳赫公司、欧里安医疗系统公司、SPmio、FMMSin​​fAPMS、FAPMS、FAPMS）

2024年，北美是介入性肿瘤器材市场最大的地区。亚太地区是全球介入性肿瘤器材市场报告中的第二大地区。介入性肿瘤器械市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。

介入性肿瘤设备市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、义大利、加拿大和西班牙。

介入性肿瘤器材市场包括栓塞、消融和支援器材的销售。该市场的商品价值为出厂价，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球介入性肿瘤设备：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球介入性肿瘤设备市场：成长率分析
  • 全球介入性肿瘤设备市场表现：规模与成长，2019-2024
  • 全球介入性肿瘤器材市场预测：规模与成长，2024-2029年，2034年
  • 全球介入性肿瘤设备：总目标市场（TAM）

第六章 市场细分

  • 全球介入性肿瘤设备市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 栓塞装置
  • 消融设备
  • 支援的设备
  • 全球介入性肿瘤器材市场（按程序、实际和预测），2019-2024 年、2024-2029 年、2034 年
  • 肿瘤热消融
  • 非热肿瘤消融
  • 经导管动脉化疗栓塞术（TACE）
  • 经导管动脉放射栓塞术（TARE）
  • 选择性体内放射疗法（SIRT）
  • 经导管动脉栓塞术（TAE）
  • 温和栓塞
  • 全球介入性肿瘤器材市场（依癌症类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 肝癌
  • 肾癌
  • 肺癌
  • 骨癌
  • 其他类型的癌症
  • 全球介入性肿瘤设备市场：栓塞设备细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 栓塞剂
  • 栓塞导管
  • 栓塞剂输送系统
  • 全球介入性肿瘤设备市场：细分：消融设备（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 射频消融术装置
  • 微波消融装置
  • 冷冻消融装置
  • 雷射消熔装置
  • 全球介入性肿瘤设备市场：按支援设备（按类型）细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 影像引导系统
  • 存取装置
  • 流体管理系统

第七章 区域和国家分析

  • 全球介入性肿瘤设备市场：区域表现及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 全球介入性肿瘤设备市场：国家、绩效及预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 介入性肿瘤设备市场：竞争格局
  • 介入性肿瘤设备市场：公司简介
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • Sirtex Medical Limited Overview, Products and Services, Strategy and Financial Analysis
    • Henlius Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Viant Medical
  • AngioDynamics Inc.
  • Pfizer
  • Steris Applied Sterilization Technologies
  • Dr.Reddys
  • CapeRay
  • Innovent Biologics
  • Novartis AG
  • Consonance
  • ABLbio
  • Adimmune
  • Heraeus Medical
  • Bioavlee
  • Mediceena International
  • Sinapi biomedical

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年介入肿瘤设备市场：提供新机会的国家
  • 2029年介入性肿瘤设备市场：细分市场将带来新机会
  • 2029年介入性肿瘤设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r25727u

Interventional oncology devices are specialized medical tools and technologies designed for the minimally invasive diagnosis and treatment of cancer. These devices enable direct targeting of tumors, allowing for treatments such as ablation or embolization, which focus on destroying cancer cells while preserving nearby healthy tissue.

The primary products within the field of interventional oncology devices include embolization devices, ablation devices, and support devices. Embolization devices are designed for the embolization of blood vessels associated with various tumors. These devices are employed in procedures such as thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization (TACE), transcatheter arterial radioembolization (TARE), selective internal radiation therapy (SIRT), and transcatheter arterial embolization (TAE) or bland embolization. These procedures are applied in the treatment of various cancer types, including liver cancer, kidney cancer, lung cancer, bone cancer, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The interventional oncology devices market research report is one of a series of new reports from The Business Research Company that provides interventional oncology devices market statistics, including interventional oncology devices industry global market size, regional shares, competitors with a interventional oncology devices market share, detailed interventional oncology devices market segments, market trends and opportunities, and any further data you may need to thrive in the interventional oncology devices industry. This interventional oncology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The interventional oncology devices market size has grown steadily in recent years. It will grow from $2.39 billion in 2024 to $2.5 billion in 2025 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to aging population pool, an increase in cancer prevalence, increase in pharmaceutical R&D expenditure, increased healthcare expenditure and growth in the number of healthcare facilities.

The interventional oncology devices market size is expected to see strong growth in the next few years. It will grow to $3.28 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing older population, increasing preference towards minimally invasive surgeries (MIS), increasing research and development spending, a rise in healthcare expenditure, high potential in emerging economies and increasing prevalence of cancer and chronic diseases. Major trends in the forecast period include focusing on developing advanced image-guided oncology devices, utilizing ai to develop innovative devices, developing new, innovative embolic devices to enable improved oncology procedures, focusing on using robotics technology and collaborating with other companies and research institutes to accelerate product development and innovation.

The forecast of 7.0% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for radioembolization microspheres and microwave ablation antennas, sourced from key regions such as Germany and Israel, which could lead to delayed cancer treatments and increased costs for minimally invasive tumor therapies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Leading companies in the interventional oncology devices market are focusing on advancements in technologies, such as tissue volume, to improve diagnostic accuracy and treatment efficacy in cancer procedures. Tissue volume refers to the quantity of biological tissue obtained during a biopsy. Collecting larger tissue samples allows for more thorough analysis, enhancing diagnostic precision and aiding in effective treatment planning. For example, in June 2023, Argon Medical, a U.S.-based medical device company, introduced the SuperCore Advantage semi-automatic biopsy device. The SuperCore Advantage collects up to 35% more tissue than competing products, reducing the need for multiple biopsy passes, which is essential for acquiring sufficient tissue for accurate diagnosis.

The high prevalence of cancer is expected to drive the growth of the interventional oncology devices market. Cancer is a group of diseases characterized by uncontrolled cell growth, leading to the formation of masses or tumors. This high prevalence creates a demand for interventional oncology devices, essential for diagnosing, treating, and managing cancer, enabling early detection, staging, and monitoring. For instance, in July 2024, the Australian Institute of Health and Welfare reported an increase in cancer diagnoses in Australia from 160,570 cases in 2022 to 164,694 in 2023, marking a significant year-over-year rise. This trend underscores the growing cancer prevalence, supporting the demand for interventional oncology devices in the market.

Companies in the interventional oncology devices market are increasingly incorporating robotics technology to enhance efficiency. Robotic systems integrate image-based planning and navigation, allowing accurate and efficient installation of instruments to specific body parts. In March 2022, the U.S. Food and Drug Administration approved Quantum Surgical's Epione interventional oncology robotics platform, showcasing the industry's commitment to technological advancements.

Major players in the interventional oncology devices market are focused on innovation, such as AI-powered digital pathology solutions, to enhance the accuracy of breast cancer diagnosis. Paige AI Inc., a U.S.-based biotechnology company, launched Paige Breast Lymph Node in March 2022, an AI-powered digital pathology solution improving the detection of breast cancer metastases in lymph node tissue. This technology offers AI-driven detection capabilities, a convenient heat map overlay, high sensitivity and specificity, seamless integration into existing workflows, user-friendliness, and robust security measures.

In August 2022, Boston Scientific Corporation acquired Obsidio Inc. for an undisclosed amount, aiming to expand its interventional oncology portfolio and strengthen its position in the growing market. Obsidio Inc., a U.S.-based medical device company, specializes in developing minimally invasive interventional oncology devices for treating liver cancer and other solid tumors.

Major companies operating in the interventional oncology devices market include Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, Henlius, Viant Medical, AngioDynamics Inc., Pfizer, Steris Applied Sterilization Technologies, Dr.Reddys, CapeRay, Innovent Biologics, Novartis AG, Consonance, ABLbio, Adimmune, Heraeus Medical, Bioavlee, Mediceena International, Sinapi biomedical, Olympus, Freudenberg Medical, Hisun Pharma, Beijing ShuangLu Pharmaceuticals, Edwards LifeSciences Corp, Gulf Dent Trading, LifeTech Scientific Corporation, Biomerics, Medtronic plc, Dickinson & Company, 3M Company, DISA Vascular, Johnson & Johnson, Eurolab, Koninklijke Philips, Quantum SurgicalKyowa Hakko Kirin, Viatris, Nipro, Zimmer Biomet Holdings, Profound Medical, Gedeon Richter, Baxter, Ti-TaMED, Abbott Laboratories, Cook Medical LLC, Adavium Medical, Autocam Medical, Bio-Thera, Stryker, GE Healthcare, Sonic Healthcare, Medicem, HealthTronics, Bayer AG, Intuitive Surgical Inc, Aster DM Healthcare, Danaher Corporation, Varian Medical Systems Inc., Smileneo, EDAP TMS S.A, Fresenius Medical Care AG, China Regenerative Medicine International

North America was the largest region in the interventional oncology devices market in 2024. Asia-Pacific was the second largest region in the global interventional oncology devices market report. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the interventional oncology devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The interventional oncology devices market consists of sales of embolization devices, ablation devices, and support devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Oncology Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interventional oncology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interventional oncology devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The interventional oncology devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Embolization Devices, Ablation Devices, Support Devices
  • 2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization
  • 3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types
  • Subsegments:
  • 1) By Embolization Devices: Embolic Agents; Catheters For Embolization; Delivery Systems For Embolic Agents
  • 2) By Ablation Devices: Radiofrequency Ablation Devices; Microwave Ablation Devices; Cryoablation Devices; Laser Ablation Devices
  • 3) By Support Devices: Imaging Guidance Systems; Access Devices; Fluid Management Systems
  • Companies Mentioned: Boston Scientific Corporation; Terumo Corporation; Siemens Healthineers; Sirtex Medical Limited; Henlius; Viant Medical; AngioDynamics Inc.; Pfizer; Steris Applied Sterilization Technologies; Dr.Reddys; CapeRay; Innovent Biologics; Novartis AG; Consonance; ABLbio; Adimmune; Heraeus Medical; Bioavlee; Mediceena International; Sinapi biomedical; Olympus; Freudenberg Medical; Hisun Pharma; Beijing ShuangLu Pharmaceuticals; Edwards LifeSciences Corp; Gulf Dent Trading; LifeTech Scientific Corporation; Biomerics; Medtronic plc; Dickinson & Company; 3M Company; DISA Vascular; Johnson & Johnson; Eurolab; Koninklijke Philips; Quantum SurgicalKyowa Hakko Kirin; Viatris; Nipro; Zimmer Biomet Holdings; Profound Medical; Gedeon Richter; Baxter; Ti-TaMED; Abbott Laboratories; Cook Medical LLC; Adavium Medical; Autocam Medical; Bio-Thera; Stryker; GE Healthcare; Sonic Healthcare; Medicem; HealthTronics; Bayer AG; Intuitive Surgical Inc; Aster DM Healthcare; Danaher Corporation; Varian Medical Systems Inc.; Smileneo; EDAP TMS S.A; Fresenius Medical Care AG; China Regenerative Medicine International
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Interventional Oncology Devices Market Characteristics

3. Interventional Oncology Devices Market Trends And Strategies

4. Interventional Oncology Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Interventional Oncology Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Interventional Oncology Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Interventional Oncology Devices Market Growth Rate Analysis
  • 5.4. Global Interventional Oncology Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Interventional Oncology Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Interventional Oncology Devices Total Addressable Market (TAM)

6. Interventional Oncology Devices Market Segmentation

  • 6.1. Global Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Embolization Devices
  • Ablation Devices
  • Support Devices
  • 6.2. Global Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Thermal Tumor Ablation
  • Non-thermal Tumor Ablation
  • Transcatheter Arterial Chemoembolization (TACE)
  • Transcatheter Arterial Radioembolization (TARE)
  • Selective Internal Radiation Therapy (SIRT)
  • Transcatheter Arterial Embolization (TAE)
  • Bland Embolization
  • 6.3. Global Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liver Cancer
  • Kidney Cancer
  • Lung Cancer
  • Bone Cancer
  • Other Cancer Types
  • 6.4. Global Interventional Oncology Devices Market, Sub-Segmentation Of Embolization Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Embolic Agents
  • Catheters For Embolization
  • Delivery Systems For Embolic Agents
  • 6.5. Global Interventional Oncology Devices Market, Sub-Segmentation Of Ablation Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiofrequency Ablation Devices
  • Microwave Ablation Devices
  • Cryoablation Devices
  • Laser Ablation Devices
  • 6.6. Global Interventional Oncology Devices Market, Sub-Segmentation Of Support Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Imaging Guidance Systems
  • Access Devices
  • Fluid Management Systems

7. Interventional Oncology Devices Market Regional And Country Analysis

  • 7.1. Global Interventional Oncology Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Interventional Oncology Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Interventional Oncology Devices Market

  • 8.1. Asia-Pacific Interventional Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Interventional Oncology Devices Market

  • 9.1. China Interventional Oncology Devices Market Overview
  • 9.2. China Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Interventional Oncology Devices Market

  • 10.1. India Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Interventional Oncology Devices Market

  • 11.1. Japan Interventional Oncology Devices Market Overview
  • 11.2. Japan Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Interventional Oncology Devices Market

  • 12.1. Australia Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Interventional Oncology Devices Market

  • 13.1. Indonesia Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Interventional Oncology Devices Market

  • 14.1. South Korea Interventional Oncology Devices Market Overview
  • 14.2. South Korea Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Interventional Oncology Devices Market

  • 15.1. Western Europe Interventional Oncology Devices Market Overview
  • 15.2. Western Europe Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Interventional Oncology Devices Market

  • 16.1. UK Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Interventional Oncology Devices Market

  • 17.1. Germany Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Interventional Oncology Devices Market

  • 18.1. France Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Interventional Oncology Devices Market

  • 19.1. Italy Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Interventional Oncology Devices Market

  • 20.1. Spain Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Interventional Oncology Devices Market

  • 21.1. Eastern Europe Interventional Oncology Devices Market Overview
  • 21.2. Eastern Europe Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Interventional Oncology Devices Market

  • 22.1. Russia Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Interventional Oncology Devices Market

  • 23.1. North America Interventional Oncology Devices Market Overview
  • 23.2. North America Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Interventional Oncology Devices Market

  • 24.1. USA Interventional Oncology Devices Market Overview
  • 24.2. USA Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Interventional Oncology Devices Market

  • 25.1. Canada Interventional Oncology Devices Market Overview
  • 25.2. Canada Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Interventional Oncology Devices Market

  • 26.1. South America Interventional Oncology Devices Market Overview
  • 26.2. South America Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Interventional Oncology Devices Market

  • 27.1. Brazil Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Interventional Oncology Devices Market

  • 28.1. Middle East Interventional Oncology Devices Market Overview
  • 28.2. Middle East Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Interventional Oncology Devices Market

  • 29.1. Africa Interventional Oncology Devices Market Overview
  • 29.2. Africa Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Interventional Oncology Devices Market Competitive Landscape And Company Profiles

  • 30.1. Interventional Oncology Devices Market Competitive Landscape
  • 30.2. Interventional Oncology Devices Market Company Profiles
    • 30.2.1. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sirtex Medical Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Henlius Overview, Products and Services, Strategy and Financial Analysis

31. Interventional Oncology Devices Market Other Major And Innovative Companies

  • 31.1. Viant Medical
  • 31.2. AngioDynamics Inc.
  • 31.3. Pfizer
  • 31.4. Steris Applied Sterilization Technologies
  • 31.5. Dr.Reddys
  • 31.6. CapeRay
  • 31.7. Innovent Biologics
  • 31.8. Novartis AG
  • 31.9. Consonance
  • 31.10. ABLbio
  • 31.11. Adimmune
  • 31.12. Heraeus Medical
  • 31.13. Bioavlee
  • 31.14. Mediceena International
  • 31.15. Sinapi biomedical

32. Global Interventional Oncology Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Interventional Oncology Devices Market

34. Recent Developments In The Interventional Oncology Devices Market

35. Interventional Oncology Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Interventional Oncology Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Interventional Oncology Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Interventional Oncology Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer